GO
Loading...

Drug Retail

More

  • Vivus' Diet Drug Approved     Wednesday, 18 Jul 2012 | 1:06 PM ET

    Just in the last month, two weight loss drugs have won the approval of the FDA, reports CNBC's Seema Mody.

  • British Banks Behaving Badly     Tuesday, 17 Jul 2012 | 1:13 PM ET

    CNBC's Eamon Javers reports on an apology made by HSBC's U.S. CEO regarding the money laundering scandal.

  • Federal prosecutors are uncovering what they say is another blatant rip-off of the Medicaid system, and U.S. Attorney Preet Bharara says 48 people are charged in a nationwide operation centered here in New York, reports CNBC's Scott Cohn.

  • Cramer: Corporate US Faced with a Tale of Two Cities Thursday, 12 Jul 2012 | 6:42 PM ET

    The "Mad Money" host gets poetic and gives investors a glimpse of how the global economy might be seen through Charles Dickens' eyes.

  • What a Year for Wal-Mart     Monday, 2 Jul 2012 | 1:37 PM ET

    Wal-Mart is responsible for 11 percent of the total U.S. retail sales, and CNBC's Courtney Reagan reports on the debate between economists over the company's costs and benefits of its impact on the retail landscape.

  • Anti-Obesity Drug a Big Win for Biotech Friday, 29 Jun 2012 | 1:36 PM ET
    Biotech

    With the weight loss market heating up, stocks like Arena Pharmaceuticals may be spelling out a big rally for the drug retail space.

  • Broken Stock or Broken Company?     Thursday, 28 Jun 2012 | 6:15 PM ET

    Last week, Celgene announced it was pulling its Revlimid application in Europe, and Mad Money host Jim Cramer explains why he thinks investors should buy into the stock now.

  • US Aircraft Plant for Airbus: NYT     Wednesday, 27 Jun 2012 | 7:25 PM ET

    Airbus plans to build its first U.S. assembly line in Alabama, Arena Pharmaceutical's new anti-obesity drug is set to hit the market early 2013, and Peter Madoff will tentatively plead guilty, reports, CNBC's Brian Shactman and Seema Mody.

  • CNBC's David Faber reports Walgreens comparable sales are down 5.8% from a year ago.

  • Cramer: 5 Earnings to Watch Wednesday Tuesday, 1 May 2012 | 11:10 AM ET

    The “Mad Money” host offers his earnings expectations for Time Warner, CVS Caremark, Garmin, Allergan and Clorox.

  • Walgreen: Ready to Rebound?     Thursday, 5 Apr 2012 | 2:50 PM ET

    Walgreen is getting a pharmacy facelift and the chain, based in Illinois, is adding fancy food, more booze and amping up its drugstores. Kermit Crawford, Walgreen president, offers insight into the company's business strategies.

  • Pharma Sector Outperforms S&P     Thursday, 29 Dec 2011 | 10:52 AM ET

    CNBC's Seema Mody reports the pharma sector is up about 8% and outperforming the S&P 500 this year.

  • Sunshine Stock     Tuesday, 27 Dec 2011 | 2:47 PM ET

    CNBC's Brian Sullivan reports today's sunshine stock, Alexion Pharmaceuticals hit an all time high today.

  • The drug developer's stock took a hit Thursday, after data was released linking an ingredient in its weight loss treatment to an increased risk of birth defects.

  • Does Allen Stanford Have Amnesia?     Tuesday, 20 Dec 2011 | 4:51 PM ET

    Accused of running a $7B ponzi scheme, Allen Stanford was in court today and CNBC's Scott Cohn has the story.

  • Cramer: 6 Things to Watch Tuesday Monday, 19 Dec 2011 | 2:15 PM ET

    The "Mad Money" host reveals what earnings and other event he plans to monitor.

  • Shoppers Stocking up at CVS     Monday, 12 Dec 2011 | 2:37 PM ET

    CNBC's Courtney Reagan reports on lifted holiday retail sales at drug stores.

  • Perrigo's CEO on Earnings     Thursday, 27 Oct 2011 | 2:35 PM ET

    A breakdown of better-than-expected earnings from the generic drug maker, with Joseph Papa, Perrigo CEO.

  • Perrigo CEO: Why Business is Growing Tuesday, 27 Sep 2011 | 6:42 PM ET

    Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.

  • Are PBH's Glory Days Over?     Friday, 16 Sep 2011 | 2:26 PM ET

    Are pharmacy benefit managers becoming obsolete? CNBC's Herb Greenberg says consumers can now buy away from their PBM and insurance plans at Costco, Walmart, Target, and Walgreens.

Most Popular Video

Thursday, 17 Apr 2014 | 5:46 PM ET

CNBC voice over talent Jim Birdsall shares the top 5 sayings from traders on "Fast Money" over the years.

Thursday, 17 Apr 2014 | 6:40 PM ET

Mad Money's Jim Cramer reflects on CNBC's evolution over the past 25 years.

Thursday, 17 Apr 2014 | 6:30 PM ET

The latest cybersecurity headlines- tax scammers have no deadline, and the Heartbleed vulnerability threatens websites. CNBC's Scott Cohn reports.